Skip to main content

Table 1 Summary of studies evaluating the effect of dietary lactose concentration on growth performance of weanling pigs used in the meta-analysis

From: The role of lactose in weanling pig nutrition: a literature and meta-analysis review

Study

Weaning age, d

Initial BW, kg

Growth promotersa

Duration of feeding, d of age

Dietary CP, %

Lactose level, %

ADFI, g/d

ADG, g/d

G:F

Nessmith et al. [43]

19

5.3

+ (AGP)

19–26

0, 20, 40

196, 215, 220

234, 252, 246

1.19, 1.18, 1.15

Nessmith et al. [43]

19

5.3

+ (AGP)

26–33

0, 20, 40

310, 301, 300

328, 322, 322

1.06, 1.08, 1.08

Nessmith et al. [60]

10

3.7

+ (AGP)

10–15

0, 20, 40

87, 104, 107

109, 119, 125

1.21, 1.16, 1.15

Nessmith et al. [60]

10

3.7

+ (AGP)

15–20

0, 20, 40

152, 180, 180

156, 181, 184

1.02, 1.00, 1.03

Tran et al. [54]

20

6.07

+ (AGP)

20–27

22%

0, 20

113, 117

50, 71

0.44, 0.61

Tran et al. [54]

20

6.07

+ (AGP)

27–34

22%

0, 20

340, 390

286, 310

0.84, 0.82

Tran et al. [54]

20

6.07

+ (AGP)

34–48

22%

0, 15

765, 828

545, 567

0.71, 0.68

Tran et al. [54]

20

6.07

+ (AGP)

48–55

22%

0, 5

1044, 1072

717, 719

0.69, 0.67

O′ Doherty et al. [47]

24

7.6

24–31

20%

15, 25

242, 239

100, 146

0.41, 0.59

O′ Doherty et al. [47]

24

7.6

31–38

20%

15, 25

415, 450

302, 325

0.75, 0.73

O′ Doherty et al. [47]

24

7.6

38–49

20%

15, 25

682, 683

438, 388

063, 0.57

O′ Doherty et al. [46]

22, 28

7, 7.7

+ (AGP)

25–32

22%

0, 17.5, 35

209, 223, 224

72, 122, 163

0.34, 0.55, 073

O′ Doherty et al. [46]

22, 28

7, 7.7

+ (AGP)

32–42

22%

0, 17.5, 35

363, 403, 404

180, 281, 265

0.46, 0.66, 0.61

O′ Doherty et al. [46]

22, 28

7, 7.7

+ (AGP)

42–50

22%

0, 17.5, 35

558, 660, 704

267, 424, 478

0.47, 0.64, 0.65

Kim et al. [48]

21

6.94

+ (AGP)

21–28

21%

15, 25

298, 335

247, 289

0.83, 0.86

Kim et al. [48]

28

9.57

+ (AGP)

28–35

21%

15, 25

542, 579

423, 461

0.78, 0.79

Pierce et al. [49]

24

7.1

24–31

20%

6.5, 17, 27.5

189, 192, 196

73, 80, 80

0.39, 0.42, 0.41

Pierce et al. [49]

24

7.1

31–38

20%

6.5, 17, 27.5

335, 329, 341

175, 224, 212

0.52, 0.68, 0.63

Pierce et al. [49]

24

7.1

38–45

20%

6.5, 17, 27.5

512, 511, 567

292, 322, 358

0.61, 0.68, 0.66

Pierce et al. [49]

24

7.1

45–52

20%

6.5, 17, 27.5

652, 677, 737

399, 461, 487

0.56, 0.65, 0.63

Pierce et al. [33]

24

6

24–31

22%

17, 29.5

254, 323

99, 179

0.39, 0.56

Pierce et al. [33]

24

6

31–38

22%

17, 29.5

441, 507

290, 331

0.66, 0.65

Pierce et al. [33]

24

6

38–45

22%

17, 29.5

757, 876

452, 527

0.6, 0.61

Mahan and Newton [50]

23

6.5

+ (AGP)

23–37

0, 22.5, 35.0

301, 338, 312

243, 278, 258

0.81, 0.82, 0.82

Bertol et al. [51]

21

 

+ (AGP)

21–35

20%

0, 7, 14, 21

240, 280, 300, 334

142, 186, 191, 219

0.55, 0.65, 0.63, 0.65

Bertol et al. [51]

19

6.3

+ (AGP)

19–26

10, 15, 20, 25, 30, 35

190, 207, 202, 214, 225, 194

84, 99, 103, 114, 130, 103

0.42, 0.48, 0.51, 0.53, 0.58, 0.53

Bertol et al. [51]

19

6.3

+ (AGP)

26–33

10, 15, 20, 25, 30, 35

401, 412, 423, 428, 421, 409

346, 349, 370, 360, 359,330

0.86, 0.85, 0.88, 0.84, 0.86, 0.83

Bertol et al. [51]

19

6.3

+ (AGP)

26–33

7, 12, 17, 22, 27, 32

421, 397, 426, 448, 427, 449

278, 285, 315, 335, 317, 331

0.66, 0.72, 0.74, 0.75, 0.74, 0.74

Bertol et al. [51]

19

6.3

+ (AGP)

33–40

7, 12, 17, 22, 27, 32

700, 690, 736, 718, 705, 718

507, 509, 525, 514, 529, 540

0.72, 0.74, 0.71, 0.70, 0.75, 0.75

Bertol et al. [51]

19

6.3

+ (AGP)

40–54

0, 5, 10, 15, 20

1095, 1104, 1106, 1124, 1135

657, 685, 678, 695, 686

0.6, 0.62, 0.61, 0.62. 0.60

Molino et al. [58]

21

6.1

+ (AGP)

21–35

21%

0, 4, 8, 12

250, 308, 280, 306

195, 244, 220, 248

0.78, 0.78, 0.78, 0.8

Cromwell et al. [59]

20

6.2

+ (AGP)

30–37

22%

0, 2.5, 5, 7.5, 10

613, 618, 643, 646, 648

467, 467, 503, 505, 506

0.76, 0.76, 0.78, 0.78, 0.78

Cromwell et al. [59]

20

6.2

+ (AGP)

37–44

22%

0, 2.5, 5, 7.5, 10

833, 830, 826, 860, 856

597, 600, 592, 610, 610

0.72, 0.73, 0.73, 0.72, 0.72

Pierce et al. [61]

21

7.6

33–45

16%

12.5, 21.5

600, 600

270, 300

0.45, 0.5

Pierce et al. [61]

21

7.6

45–54

16%

12.5, 21.5

920, 870

520, 490

0.55, 0.51

Pierce et al. [61]

21

7.6

33–45

18.5%

12.5, 21.5

650, 640

400, 380

0.61, 0.59

Pierce et al. [61]

21

7.6

45–54

18.5%

12.5, 21.5

1070, 890

620, 590

0.56, 0.66

Pierce et al. [61]

21

7.6

33–45

21%

12.5, 21.5

600, 700

400, 400

0.67, 0.59

Pierce et al. [61]

21

7.6

45–54

21%

12.5, 21.5

970, 1100

570, 700

0.6, 0.63

O′ Connell et al. [62]

24

6

24–31

20%

17, 27.5

190, 212

104, 121

0.55, 0.57

O′ Connell et al. [62]

24

6

31–38

20%

17, 27.5

434, 462

364, 394

0.84, 0.85

O′ Connell et al. [62]

24

6

38–49

20%

17, 27.5

615, 691

422, 475

0.69, 0.69

O′ Connell et al. [62]

24

6

49–57

20%

17, 27.5

870, 883

561, 538

0.65, 0.61

  1. a+ indicates the use of in feed antibiotic growth promotors (AGP) and/or pharmacological dose of ZnO (> 1500 ppm) and/or pharmacological dose of CuSO4 (> 150 ppm). ADFI Average daily feed intake, ADG Average daily gain, BW Body weight, CP Crude protein, G:F The ratio of weight gain to feed intake